Observational studyInternational journal of medical sciences2021

Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.

Ye Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.